Use this banner section for site-wide announcements, news updates, big changes and more.
InVision obtains FDA 510k Clearance for Breakthrough Device, InVision Precision Cardiac Amyloid
InVision enters artificial intelligence collaboration with Alexion to explore potential to improve detection of cardiac amyloidosis
Business

InVision enters artificial intelligence collaboration with Alexion to explore potential to improve detection of cardiac amyloidosis

InVision receives U.S. FDA Clearance for Precision LVEF

InVision receives U.S. FDA Clearance for Precision LVEF

InVision Announces Adoption of New CPT Billing Code for InVision Precision Cardiac Amyloid by the American Medical Association

InVision Announces Adoption of New CPT Billing Code for InVision Precision Cardiac Amyloid by the American Medical Association

InVision receives U.S. FDA Breakthrough Device Designation for its Cardiac Amyloidosis Algorithm

InVision receives U.S. FDA Breakthrough Device Designation for its Cardiac Amyloidosis Algorithm

Our approach to onboarding team members
Product

Our approach to onboarding team members

Write a brief description of the article here.
Measuring customer satisfaction.
Business

Measuring customer satisfaction.

Write a brief description of the article here.
Perfecting the packaging experience.
Product

Perfecting the packaging experience.

Write a brief description of the article here.
Facilitating actionable feedback.
Business

Facilitating actionable feedback.

Write a brief description of the article here.
Customers achieve great results when they switch to Adept.
Arrange a demo
© Copyright – InVision Medical Technology
Get in touch with us:
founders@invisionmedtech.com
‍
Quality Policy

Search

Enter keywords and click search.